Literature DB >> 23415952

In vitro and in vivo models for the study of oral delivery of nanoparticles.

Jennifer M Gamboa1, Kam W Leong.   

Abstract

Oral delivery is an attractive route to deliver therapeutics via nanoparticles due to its ease of administration and patient compliance. This review discusses laboratory techniques for studying oral delivery of nanoparticles, which offer protection of cargo through the gastrointestinal tract. Some of the difficulties in modeling oral delivery include the harsh acidic environment, variable pH, and the tight monolayer of endothelial cells present throughout the gastrointestinal tract. The use of in vitro techniques including the Transwell ® system, simulated gastric/intestinal fluid, and diffusion chambers addresses these challenges. When studying effects after oral delivery in vivo, bioimaging of nanoparticle biodistribution using radioactive markers has been popular. Functional assays such as immune response and systemic protein concentration analysis can further define the merits of the oral delivery systems. As biologics become increasingly more important in chronic therapies, nanoparticle-mediated oral delivery will assume greater prominence, and more sophisticated in vitro and in vivo models will be required.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23415952      PMCID: PMC3773489          DOI: 10.1016/j.addr.2013.01.003

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  77 in total

1.  Evaluation of nano- and microparticle uptake by the gastrointestinal tract.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-12-01       Impact factor: 15.470

2.  Effect of chitosan on epithelial cell tight junctions.

Authors:  Jennifer Smith; Edward Wood; Michael Dornish
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

3.  Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles.

Authors:  Luz Cristal Glangchai; Mary Caldorera-Moore; Li Shi; Krishnendu Roy
Journal:  J Control Release       Date:  2007-11-04       Impact factor: 9.776

4.  Use of simulated intestinal fluids with Caco-2 cells and rat ileum.

Authors:  N Patel; B Forbes; S Eskola; J Murray
Journal:  Drug Dev Ind Pharm       Date:  2006-02       Impact factor: 3.225

5.  Fc-mediated transport of nanoparticles across airway epithelial cell layers.

Authors:  Driton Vllasaliu; Cameron Alexander; Martin Garnett; Mike Eaton; Snow Stolnik
Journal:  J Control Release       Date:  2011-12-20       Impact factor: 9.776

6.  Quantitative modeling of selective lysosomal targeting for drug design.

Authors:  Stefan Trapp; Gus R Rosania; Richard W Horobin; Johannes Kornhuber
Journal:  Eur Biophys J       Date:  2008-05-27       Impact factor: 1.733

7.  Measurement of gastrointestinal pH profiles in normal ambulant human subjects.

Authors:  D F Evans; G Pye; R Bramley; A G Clark; T J Dyson; J D Hardcastle
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

8.  Simulated intestinal fluid as transport medium in the Caco-2 cell culture model.

Authors:  F Ingels; S Deferme; E Destexhe; M Oth; G Van den Mooter; P Augustijns
Journal:  Int J Pharm       Date:  2002-01-31       Impact factor: 5.875

9.  The turnover of the epithelium of the small intestine.

Authors:  B Creamer
Journal:  Br Med Bull       Date:  1967-09       Impact factor: 4.291

10.  Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.

Authors:  Jong-Ho Kim; Yoo-Shin Kim; Kyeongsoon Park; Eunah Kang; Seulki Lee; Hae Yun Nam; Kwangmeyung Kim; Jae Hyung Park; Dae Yoon Chi; Rang-Woon Park; In-San Kim; Kuiwon Choi; Ick Chan Kwon
Journal:  Biomaterials       Date:  2008-04       Impact factor: 12.479

View more
  42 in total

1.  Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis.

Authors:  Jiang-Jiang Qin; Wei Wang; Sushanta Sarkar; Ruiwen Zhang
Journal:  J Control Release       Date:  2016-07-06       Impact factor: 9.776

2.  Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.

Authors:  Richard A Graves; Grace A Ledet; Elena Y Glotser; Demaurian M Mitchner; Levon A Bostanian; Tarun K Mandal
Journal:  Eur J Pharm Sci       Date:  2015-04-28       Impact factor: 4.384

Review 3.  The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.

Authors:  Nazanin Hoshyar; Samantha Gray; Hongbin Han; Gang Bao
Journal:  Nanomedicine (Lond)       Date:  2016-03-22       Impact factor: 5.307

Review 4.  Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.

Authors:  Abhijit A Date; Justin Hanes; Laura M Ensign
Journal:  J Control Release       Date:  2016-06-09       Impact factor: 9.776

Review 5.  Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors.

Authors:  Zonghua Tian; Yaping Mai; Tingting Meng; Shijie Ma; Guojing Gou; Jianhong Yang
Journal:  AAPS PharmSciTech       Date:  2021-06-14       Impact factor: 3.246

6.  Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects.

Authors:  José Lopes-de-Araújo; Ana Rute Neves; Virgínia M Gouveia; Catarina C Moura; Cláudia Nunes; Salette Reis
Journal:  Pharm Res       Date:  2015-09-09       Impact factor: 4.200

Review 7.  Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems.

Authors:  Tahnee J Dening; Shasha Rao; Nicky Thomas; Clive A Prestidge
Journal:  AAPS J       Date:  2015-09-09       Impact factor: 4.009

8.  The Role of Metal Oxide Nanoparticles, Escherichia coli, and Lactobacillus rhamnosus on Small Intestinal Enzyme Activity.

Authors:  Alba García-Rodríguez; Fabiola Moreno-Olivas; Ricard Marcos; Elad Tako; Cláudia N H Marques; Gretchen J Mahler
Journal:  Environ Sci Nano       Date:  2020-11-09

Review 9.  Design and implementation of novel nutraceuticals and derivatives for treating intestinal disorders.

Authors:  Maria J Barahona; Vanessa Baratta; Jenna Ollodart; David Mulligan; John P Geibel
Journal:  Future Med Chem       Date:  2019-04-17       Impact factor: 3.808

10.  Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury.

Authors:  Mandy B Esch; Gretchen J Mahler; Tracy Stokol; Michael L Shuler
Journal:  Lab Chip       Date:  2014-08-21       Impact factor: 6.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.